Clinical Trial Update: To Determine Safe and Effective Dose of Sotatercept for the Treatment of Chemotherapy Induced Anemia in Participants With Advanced Non-small Cell Lung Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial update testing sotatercept for chemotherapy-induced anemia in patients with advanced non-small cell lung cancer. The study was terminated, and res…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anemia
• Non-small Cell Lung Cancer

Drugs mentioned

• Sotatercept (sotatercept)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Anemia, Carcinoma, Non-Small-Cell Lung | Phase 2 | Status: TERMINATED | Results posted: 2023-10-31